Connecting - News - Information
Thursday, 6 December 2018
PHASE 2 INTERIM DATA EVALUATING THE COMBINATION OF PRACINOSTAT AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME PRESENTED AT THE 2018 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
PHASE 2 INTERIM DATA EVALUATING THE COMBINATION OF PRACINOSTAT AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME PRESENTED AT THE 2018 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment